Proteomics market shows rapid growth

Sudbury/UK – The proteomics market grew from 1.1 billion US dollar in 2001 to almost 1.4 billion US dollar in 2002 and, according to a new report by Select Biosciences of Sudbury, England, the growth rate is continuing in 2003.
Prepared in San Francisco, California by Dr Steven Bodovitz, Proteomics 2003 presents a detailed market model and thorough analysis of the technologies and business strategies of 75 leading proteomics companies. Proteomics 2003 projects that the market will grow to more than 2.5 billion US dollar by 2008, a compound annual growth rate of more than 14%. Proteomics 2003 is based on extensive primary and secondary research, including interviews with company representatives. It discusses the background of the three main market applications : Drug Target /Biomarker discovery and validation, Drug development, Clinical trials and Diagnostics.